Patents by Inventor Kimberly Sogi

Kimberly Sogi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis
    Patent number: 11224646
    Abstract: A vaccine against Mycobacterium tuberculosis (M. tuberculosis) formulated for intranasal administration, comprises a first vaccine component comprising one or more M. tuberculosis, Mycobacterium vaccae (M. vaccae) or Mycobacteroium bovis (M. bovis) antigens, and a second vaccine component comprising a Stimulator of Interferon Genes (STING) activator.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: January 18, 2022
    Assignee: The Regents of the University of California
    Inventors: Sarah Stanley, Erik Van Dis, Kimberly Sogi, Daniel A. Portnoy, Chris Rae
  • Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis
    Publication number: 20200338182
    Abstract: A vaccine against Mycobacterium tuberculosis (M. tuberculosis) formulated for intranasal administration, comprises a first vaccine component comprising one or more M. tuberculosis, Mycobacterium vaccae (M. vaccae) or Mycobacteroium bovis (M. bovis) antigens, and a second vaccine component comprising a Stimulator of Interferon Genes (STING) activator.
    Type: Application
    Filed: July 7, 2020
    Publication date: October 29, 2020
    Applicant: The Regents of the University of California
    Inventors: Sarah Stanley, Erik Van Dis, Kimberly Sogi, Daniel A. Portnoy, Chris Rae